415 related articles for article (PubMed ID: 24616503)
1. Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis.
Yang C; Wang H; Qiao T; Yang B; Aliaga L; Qiu L; Tan W; Salameh J; McKenna-Yasek DM; Smith T; Peng L; Moore MJ; Brown RH; Cai H; Xu Z
Proc Natl Acad Sci U S A; 2014 Mar; 111(12):E1121-9. PubMed ID: 24616503
[TBL] [Abstract][Full Text] [Related]
2. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
3. Low-level overexpression of wild type TDP-43 causes late-onset, progressive neurodegeneration and paralysis in mice.
Yang C; Qiao T; Yu J; Wang H; Guo Y; Salameh J; Metterville J; Parsi S; Yusuf I; Brown RH; Cai H; Xu Z
PLoS One; 2022; 17(2):e0255710. PubMed ID: 35113871
[TBL] [Abstract][Full Text] [Related]
4. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS.
Mitchell JC; Constable R; So E; Vance C; Scotter E; Glover L; Hortobagyi T; Arnold ES; Ling SC; McAlonis M; Da Cruz S; Polymenidou M; Tessarolo L; Cleveland DW; Shaw CE
Acta Neuropathol Commun; 2015 Jun; 3():36. PubMed ID: 26108367
[TBL] [Abstract][Full Text] [Related]
5. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
[TBL] [Abstract][Full Text] [Related]
6. TDP-43-The key to understanding amyotrophic lateral sclerosis.
Xu Z; Yang C
Rare Dis; 2014; 2(1):e944443. PubMed ID: 26942097
[TBL] [Abstract][Full Text] [Related]
7. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD.
Diaper DC; Adachi Y; Lazarou L; Greenstein M; Simoes FA; Di Domenico A; Solomon DA; Lowe S; Alsubaie R; Cheng D; Buckley S; Humphrey DM; Shaw CE; Hirth F
Hum Mol Genet; 2013 Oct; 22(19):3883-93. PubMed ID: 23727833
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration.
Wegorzewska I; Bell S; Cairns NJ; Miller TM; Baloh RH
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18809-14. PubMed ID: 19833869
[TBL] [Abstract][Full Text] [Related]
9. A robust TDP-43 knock-in mouse model of ALS.
Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
[TBL] [Abstract][Full Text] [Related]
10. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
[TBL] [Abstract][Full Text] [Related]
11. Genetic strategies to study TDP-43 in rodents and to develop preclinical therapeutics for amyotrophic lateral sclerosis.
Wang DB; Gitcho MA; Kraemer BC; Klein RL
Eur J Neurosci; 2011 Oct; 34(8):1179-88. PubMed ID: 21777407
[TBL] [Abstract][Full Text] [Related]
12. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction.
Gordon D; Dafinca R; Scaber J; Alegre-Abarrategui J; Farrimond L; Scott C; Biggs D; Kent L; Oliver PL; Davies B; Ansorge O; Wade-Martins R; Talbot K
Neurobiol Dis; 2019 Jan; 121():148-162. PubMed ID: 30290270
[TBL] [Abstract][Full Text] [Related]
13. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
[TBL] [Abstract][Full Text] [Related]
14. Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients.
Bennett CL; Dastidar SG; Ling SC; Malik B; Ashe T; Wadhwa M; Miller DB; Lee C; Mitchell MB; van Es MA; Grunseich C; Chen Y; Sopher BL; Greensmith L; Cleveland DW; La Spada AR
Acta Neuropathol; 2018 Sep; 136(3):425-443. PubMed ID: 29725819
[TBL] [Abstract][Full Text] [Related]
15. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.
Iguchi Y; Katsuno M; Niwa J; Takagi S; Ishigaki S; Ikenaka K; Kawai K; Watanabe H; Yamanaka K; Takahashi R; Misawa H; Sasaki S; Tanaka F; Sobue G
Brain; 2013 May; 136(Pt 5):1371-82. PubMed ID: 23449777
[TBL] [Abstract][Full Text] [Related]
16. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
[TBL] [Abstract][Full Text] [Related]
17. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43.
Arnold ES; Ling SC; Huelga SC; Lagier-Tourenne C; Polymenidou M; Ditsworth D; Kordasiewicz HB; McAlonis-Downes M; Platoshyn O; Parone PA; Da Cruz S; Clutario KM; Swing D; Tessarollo L; Marsala M; Shaw CE; Yeo GW; Cleveland DW
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):E736-45. PubMed ID: 23382207
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43.
Stribl C; Samara A; Trümbach D; Peis R; Neumann M; Fuchs H; Gailus-Durner V; Hrabě de Angelis M; Rathkolb B; Wolf E; Beckers J; Horsch M; Neff F; Kremmer E; Koob S; Reichert AS; Hans W; Rozman J; Klingenspor M; Aichler M; Walch AK; Becker L; Klopstock T; Glasl L; Hölter SM; Wurst W; Floss T
J Biol Chem; 2014 Apr; 289(15):10769-10784. PubMed ID: 24515116
[TBL] [Abstract][Full Text] [Related]
19. Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats.
Huang C; Tong J; Bi F; Zhou H; Xia XG
J Clin Invest; 2012 Jan; 122(1):107-18. PubMed ID: 22156203
[TBL] [Abstract][Full Text] [Related]
20. Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.
Spiller KJ; Cheung CJ; Restrepo CR; Kwong LK; Stieber AM; Trojanowski JQ; Lee VM
J Neurosci; 2016 Jul; 36(29):7707-17. PubMed ID: 27445147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
